CANDACE VANDIVER: Open Payments
NPI 1720451222 · BETHLEHEM, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$463 in 20 payments from 13 companies in 2025. Trend: 2023 $324 · 2024 $541 · 2025 $463
Food & beverage: $463
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $82 |
| Abbott Laboratories | 2 | $46 |
| Dexcom, Inc. | 2 | $45 |
| Novo Nordisk Inc | 2 | $45 |
| Exact Sciences Corporation | 2 | $43 |
| GlaxoSmithKline, LLC. | 1 | $34 |
| Eisai Inc. | 1 | $32 |
| Edwards Lifesciences Corporation | 1 | $32 |
| Alkermes, Inc. | 1 | $28 |
| Phathom Pharmaceuticals, Inc. | 1 | $23 |
Products named: FREESTYLE LIBRE 3, Dexcom G6 Transmitter, Wegovy, BREZTRI, NUCALA, Leqembi, SAPIEN 3 Ultra RESILIA, VIVITROL.
Industry payments across GA — which companies pay providers there.
